NCT00668044

Ciprofloxacin on Burned Patients

A Population Pharmacokinetics Study of Plasma Levels of Ciprofloxacin Following a Regimen of Repeated Dose I.V. Administration (400 mg TID) on Burn Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This was a non randomised, multi center, italian study performed in burn patients receiving an antibiotic (ciprofloxacin) in order to treat an active infection. The aim of the study was to validate a pharmacokinetics model useful to verify if a standard dose regimen of ciprofloxacin, given to patients with a compromised metabolism, is a correct dose or instead is over or under dosed.

Conditions

• Burns
• Bacterial Infections

Interventions

Type	Name	Description
DRUG	Ciprofloxacin (BAYO9867)	400 mg iv BID
DRUG	Ciprofloxacin (BAYO9867)	400 mg iv TID

Timeline

• Start date: 2002-11-01
• Primary completion: 2003-11-01
• Completion: 2003-11-01
• First posted: 2008-04-28
• Last updated: 2009-10-27

Locations

7 sites across 1 country: Italy